🇫🇷
Vaxinano is a clinical-stage biotech company that developed a proprietary nanoparticle vaccine platform named Stellar-NP. The company offers efficient and safe nasal vaccines to protect animals and humans against infectious diseases. The company demonstrated the uniqueness of the adjuvant-free and high-stability vaccinal platform and unmatched results in parasitosis.
We seek to customise the content to the segments we serve.
These are both fund investors and the entrepreneurs with whom we have created alliances.
We are happy to keep in touch.
